Agilon Health, Inc.
AGLNYSEHealthcare● Active
$96.61
+$1.28(+1.34%)
Market Cap$1.6B
P/E Ratio—
52W High$101.7603
52W Low$7.48
Agilon Health, Inc. (AGL) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AGL · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.39B) | ($0.26B) | ($0.26B) | ($0.11B) | ($0.41B) |
| Depreciation & Amort. | $0.03B | $0.02B | $0.02B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.05B | $0.05B | $0.07B | $0.03B | $0.29B |
| Change in Working Capital | $0.19B | $0.13B | ($0.01B) | ($0.06B) | ($0.06B) |
| Net Cash from Operations | ($0.11B) | ($0.06B) | ($0.16B) | ($0.13B) | ($0.15B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.01B) | ($0.03B) | ($0.03B) | ($0.01B) |
| Purchases of Investments | ($0.06B) | ($0.01B) | ($0.11B) | ($0.46B) | ($0.01B) |
| Sales of Investments | $0.19B | $0.21B | $0.16B | $0.05B | $0.01B |
| Net Cash from Investing | $0.09B | $0.14B | ($0.04B) | ($0.44B) | ($0.09B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.00B) | $0.00B | ($0.20B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | ($0.00B) | ($0.01B) | ($0.01B) | ($0.02B) |
| Net Cash from Financing | ($0.00B) | ($0.00B) | ($0.19B) | $0.03B | $1.15B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.12B) | ($0.07B) | ($0.19B) | ($0.16B) | ($0.16B) |
| FCF Margin %(computed) | -2.01% | -1.17% | -4.33% | -6.84% | -10.62% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Agilon Health, Inc. data
About Agilon Health, Inc. (AGL) Cash Flow Statement
Agilon Health, Inc. generated operating cash flow of ($0.11B) and free cash flow of ($0.12B) for 2025 — a FCF margin of -2.01%. Capital expenditure was ($0.01B).
Frequently asked questions
AGL · 4 questionsAgilon Health, Inc. generated free cash flow of ($0.12B) for 2025, down 67.5% year-over-year.
AGL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10